Recruiting
Phase 2

LB-P8

Sponsor:

LISCure Biosciences

Code:

NCT06699121

Conditions

Primary Sclerosing Cholangitis (PSC)

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

LB-P8 low-dose

LB-P8 high-dose

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-06. This information was provided to ClinicalTrials.gov by LISCure Biosciences on 2025-10-24.